Lynn Okamoto, Pharm.D., has been named executive vice president of the Late Stage Business Unit at inVentiv Health Clinical, effective March 3rd. Dr. Okamoto has experience as global manager with expertise in healthcare analytics and health outcomes research. She joins the company from Evidera, where she served as senior vice president and senior research scientist of Health Economics & Epidemiology. Previously she led the Intelligent Health Repository at NDC Health.
"inVentiv Health was built for this new marketplace, with the broadest range of convergent services in the industry," said Raymond Hill, president inVentiv Health Clinical. "Our Late Stage Clinical group works seamlessly with inVentiv experts in study design and implementation, market access, reimbursement, stakeholder relations and scientific communications to anticipate the questions that will be asked in the marketplace and assure our clients are armed with effective answers."